We studied serum content of some polyunsaturated fatty acids and their correlations with parameters of oxidative stress (FORT), antioxidant protection (FORD), lipoprotein-associated phospholipase A2 (LP-PLA2), and serum level of LPO products in male patients with coronary atherosclerosis. The mass fraction of polyunsaturated fatty acids and FORD were lower, while LP-PLA2, FORT, and concentration of LPO products were higher than in the control group (conventionally healthy men). Negative correlations of medium strength of polyunsaturated fatty acids with inflammation markers and oxidative stress were revealed, which can indicate that the decrease in polyunsaturated fatty acids content is associated with enhanced generation of free radicals, and consequently with increased risk of early atherosclerosis development.
Similar content being viewed by others
References
Voronina TA. The role of oxidative stress and antioxidants in different disadapation genesis. Farmatsia Farmakologiya. 2015;(S1):8-17. Russian.
Geleskhanova YuN. Lipoprotein-associated phospholipase A2 (LP-PLA2) role in the development of vascular complications of atherosclerosis and possibility of therapeutic correction. Vestn. Kyrgyz.-Ross. Slav. Univer. 2015;15(7):48-53. Russian.
Diagnosis and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis: Russian recommendations V revision. Ateroscleroz Dislipidemii. 2012;(4):5-52. Russian.
Osipenko AN, Akulich NV, Klishevich FN. Fatty acids the blood and their correlations in atherosclerosis. Tavrich. Med.- Biol. Vestn. 2012;15(3-2):197-199. Russian.
Yuryeva EA, Sukhorukov VS, Vozdvizhenskaya ES, Novikova NN. Atherosclerosis: Hypotheses and theories. Ross. Vestn. Perinatol. Pediatr. 2014;59(3):6-16. Russian.
Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, Harrison DG, Quyyumi AA, Vaccarino V. Association between novel oxidative stress markers and Creactive protein among adults without clinical coronary heart disease. Atherosclerosis. 2005;178(1):115-121.
Amano T, Matsubara T, Uetani T, Kato M, Kato B, Yoshida T, Harada K, Kumagai S, Kunimura A, Shinbo Y, Kitagawa K, Ishii H, Murohara T. Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: an integrated backscatter intravascular ultrasound study. Atherosclerosis. 2011;218(1):110-116.
Azzi A. Oxidative stress: A dead end or laboratory hypothesis. Biochem. Biophys Res. Commun. 2007;362(2):230-232.
Colley KJ, Wolfert RL, Cobble ME. Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA J. 2011;2(1):27-38.
Giordano FJ. Oxygen, oxidative stress, hypoxia and heart failure. J. Clin. Invest. 2005;115(3):500-508.
Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y; JELIS Investigators. Relationships between plasma fatty acid composition and coronary artery disease. J. Atheroscler. Thromb. 2011;18(2):99-107.
Korngold EC, Jaffer FA, Weissleder R, Sosnovik DE. Noninvasive imaging of apoptosis in cardiovascular disease. Heart Fail Rev. 2008;13(2):163-173.
Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnström P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL. Imaging atherosclerotic plaque inflammation with fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708-2711.
Schulze PC, Lee RT. Oxidative Stress and Atherosclerosis. Curr. Atheroscler. Rep. 2005;7(3):242-248.
Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004;84(4):1381-1478.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 7, pp. 14-17, July, 2018
Rights and permissions
About this article
Cite this article
Shramko, V.S., Polonskaya, Y.V., Morozov, S.V. et al. Polyunsaturated Fatty Acids and Their Correlations with Parameters of Oxidative/Antioxidant Potential of the Blood and Lipoprotein-Associated Phospholipase A2 in Coronary Atherosclerosis. Bull Exp Biol Med 166, 11–14 (2018). https://doi.org/10.1007/s10517-018-4277-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4277-5